Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GNMSF) Change in Taxes (2023 - 2025)

Historic Change in Taxes for Genmab A (GNMSF) over the last 3 years, with Q4 2025 value amounting to -$143.0 million.

  • Genmab A's Change in Taxes fell 18600.0% to -$143.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$460.0 million, marking a year-over-year decrease of 36464.65%. This contributed to the annual value of -$460.0 million for FY2025, which is 82000.0% down from last year.
  • Latest data reveals that Genmab A reported Change in Taxes of -$143.0 million as of Q4 2025, which was down 18600.0% from -$2.0 million recorded in Q3 2025.
  • Genmab A's Change in Taxes' 5-year high stood at -$2.0 million during Q3 2024, with a 5-year trough of -$268.0 million in Q2 2025.
  • In the last 3 years, Genmab A's Change in Taxes had a median value of -$48.5 million in 2024 and averaged -$89.2 million.
  • As far as peak fluctuations go, Genmab A's Change in Taxes skyrocketed by 6774.19% in 2024, and later crashed by 18600.0% in 2025.
  • Over the past 3 years, Genmab A's Change in Taxes (Quarter) stood at -$155.0 million in 2023, then skyrocketed by 67.74% to -$50.0 million in 2024, then plummeted by 186.0% to -$143.0 million in 2025.
  • Its Change in Taxes was -$143.0 million in Q4 2025, compared to -$2.0 million in Q3 2025 and -$268.0 million in Q2 2025.